Sodium salicylate andsulphasalazine have less of this activity, however,but all of thesesalicylates were able to inhibit capillary degeneration in retinas of diabeticrats [74], suggesting that their common action to inhibit retinopathy was viainhibition of the NF-κB pathway. The gene discussed is NFKB1; the disease is retinal disorder.